Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation (M'RHICO)

May 28, 2026 updated by: University Hospital, Toulouse
This study aims to compare 2 alveolar recruitment maneuvers (ARM) in patients with cerebral injuries and acute respiratory distress syndrome (ARDS) in term of efficacy and tolerance.

Study Overview

Detailed Description

Two ARM are compared in this study:

  • The eSigh or extended sigh with increase of PEEP for 10 minutes to maintain plateau pressure at 40 cmH2O. During ARM, the peak pressure is limited to 50 cm H2O with decrease of tidal volume (Vt) if necessary.
  • The continuous positive airway pressure, or Continuous Positive Airway Pressure (CPAP) with application of a positive pressure of 40 cm H2O for 40 seconds without tidal volume.

Patients are randomized to receive in cross-over 2 ARM: CPAP and Extended Sigh (eSigh). The following data: oxygen tissue partial pressure (PtiO2), respiratory parameters, systemic and intracerebral hemodynamic parameters are collected before, after 1 minute, 10 minutes and 60 minutes for each ARM.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 140033
        • UH Caen
      • Clermont-Ferrand, France, 63003
        • UH Clermont-Ferrand
      • Montpellier, France, 34295
        • UH Montpellier
      • Nantes, France, 44093
        • UH Nantes
    • Midi Pyrénées
      • Toulouse, Midi Pyrénées, France, 31059
        • UH Toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with brain injuries (subarachnoid hemorrhage, traumatic brain injury, ischemic and hemorrhagic stroke)
  • Patients with moderate and severe ARDS criteria (as defined by classification of Berlin)
  • Patients under mechanical ventilation

Exclusion Criteria:

  • ICP (Intracranial pressure) > 25 mmHg
  • Pregnant women
  • Patients with history of chronic respiratory disease
  • Patients with bronchopleural fistula
  • Patients with hemodynamic instability despite appropriate measures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Alveolar recruitment maneuvers Group 1
alveolar recruitment maneuvers by CPAP then alveolar recruitment maneuvers by eSigh

Patients are randomized to receive in cross-over 2 ARM: CPAP at first and then eSigh.

The continuous positive airway pressure, or CPAP with application of a positive pressure of 40 cmH2O for 40 seconds without tidal volume.

The eSigh or extended sigh with increase of PEEP for 10 minutes to maintain plateau pressure at 40 cmH2O. During ARM, the peak pressure is limited to 50 cmH2O with decrease of tidal volume (Vt) if necessary.

The following data: PtiO2, respiratory parameters, systemic and intracerebral hemodynamic parameters are collected before, after 1 minute, 10 minutes and 60 minutes for each ARM.

Experimental: Alveolar recruitment maneuvers Group 2
alveolar recruitment maneuvers by eSigh then alveolar recruitment maneuvers by CPAP

Patients are randomized to receive in cross-over 2 ARM: eSigh at first and then CPAP.

The eSigh or extended sigh with increase of PEEP for 10 minutes to maintain plateau pressure at 40 cmH2O. During ARM, the peak pressure is limited to 50 cmH2O with decrease of tidal volume (Vt) if necessary.

The continuous positive airway pressure, or CPAP with application of a positive pressure of 40 cmH2O for 40 seconds without tidal volume.

The following data: PtiO2, respiratory parameters, systemic and intracerebral hemodynamic parameters are collected before, after 1 minute, 10 minutes and 60 minutes for each ARM.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of oxygen tissue partial pressure (PtiO2) values
Time Frame: 60 minutes
The comparison of PtiO2 values (mmHg, mean ± SD) 60 minutes after the 2 ARM: eSigh and CPAP
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of systemic hemodynamic parameters
Time Frame: 60 minutes
Comparison between the two ARM of systemic hemodynamic parameters: mean arterial pressure, heart rate and cardiac output.
60 minutes
Comparison of Intracranial hemodynamic parameters
Time Frame: 60 minutes
Comparison between the two ARM of Intracranial hemodynamic parameters: ICP (Intracranial pressure) , cerebral perfusion pressure and Transcranial Doppler (pulsatility index, mean, systolic and diastolic velocities)
60 minutes
Comparison of blood oxygen level
Time Frame: 60 minutes
Comparison between the two ARM of haematosis: Blood oxygen level (SpO2)
60 minutes
Comparison of partial pressure of carbon dioxide
Time Frame: 60 minutes
Comparison between the two ARM of partial pressure of carbon dioxide (PaCO2),
60 minutes
Comparison of arterial blood gases
Time Frame: 60 minutes
Comparison between the two ARM of arterial blood gases (partial pressure of oxygen (PaO2),
60 minutes
Comparison of end-tidal CO2
Time Frame: 60 minutes
Comparison between the two ARM of end-tidal CO2
60 minutes
Comparison of Respiratory parameters
Time Frame: 60 minutes
Comparison between the two ARM of Respiratory parameters: plateau pressure and static lung compliance.
60 minutes
Comparison of PtiO2
Time Frame: 60 minutes
Comparison between the two ARM of PtiO2
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ségolène MROZEK, MD, UH Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

May 16, 2022

Study Completion (Actual)

May 16, 2022

Study Registration Dates

First Submitted

September 19, 2015

First Submitted That Met QC Criteria

October 8, 2015

First Posted (Estimated)

October 12, 2015

Study Record Updates

Last Update Posted (Actual)

June 1, 2026

Last Update Submitted That Met QC Criteria

May 28, 2026

Last Verified

May 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome (ARDS)

Clinical Trials on alveolar recruitment maneuvers group 1

Subscribe